A biopsychosocial proposal to progress the field of anorexia nervosa

J. Russell
{"title":"A biopsychosocial proposal to progress the field of anorexia nervosa","authors":"J. Russell","doi":"10.1177/0004867419887792","DOIUrl":null,"url":null,"abstract":"Anorexia nervosa remains vexing to treat with the illness having a decadeslong trajectory in most patients, even those in whom intervention has been early. Despite the severe, enduring and often relapsing course, 75% or more ultimately do recover. Mortality rate from the illness, high though it is, has been reduced with better medical salvage and management of the longterm complications but suicide rate increases after 15 years of illness particularly in the context of substance abuse and socioeconomic disadvantage. Neuroprogression has been mooted but thus far has not been satisfactorily distinguished from the effects of continuing brain starvation (Russell et al., 2019). Anorexia nervosa bears some resemblance to other serious mental illnesses where a substantial number of sufferers remain symptomatic with cognitive and social decline despite what Phillipou et al. (2019) describe rather naively as ‘effective evidencebased treatments’. Genetic studies have shown an overlap between schizophrenia, mood disorders and anorexia nervosa. Autistic social deficits and cognitive rigidity may be premorbid in anorexia nervosa but are exacerbated by weight loss and serve to lock the sufferer into a self-perpetuating vicious cycle. The prospect of eventual full recovery, however, sets anorexia nervosa apart from other serious mental illnesses (Russell et al., 2019). Of course, effective biological treatment for anorexia nervosa does exist – namely refeeding or nutritional rehabilitation. This can bring about complete resolution of physical, endocrine and psychological symptoms, as documented from the earliest descriptions of the condition. However, it is not always easy to effect (or to complete), often unacceptable to patients and even their families who may see it as persecutory. Maintaining the improved state of nourishment is another challenge, with the patient often unable or unwilling to continue with the behavioural changes. Shifting the patient’s mind-set around this and correcting the system of perverse reward in a lasting way continue to be extraordinarily difficult despite involvement of family and friends as cotherapists and numerous proven psychological treatments. These have been informed by the role of diverse factors such as temperament, traits, emotional skills, trauma and distorted body image in aetiogenesis and perpetuation (Keiser et al., 2016; Russell et al., 2019). The main source of difficulty psychologically is that patients with anorexia nervosa with few exceptions differ from patients with most other mental or physical illnesses in that they are unwilling to relinquish their symptoms (i.e. emaciation and engagement in nourishment controlling behaviours) as these seem to assuage a pervasively low sense of self-worth and lack of agency. This reluctance underpins the egosyntonicity, dishonesty and treatment sabotage so frustrating to carers and clinicians (Russell et al., 2019). Patients for their part often feel hopeless to change. Psychotropic medications have been shown to reduce quasi psychotic and obsessive symptoms and to promote weight gain. Anxiety and depression are consequences of prolonged brain starvation (if not premorbid) and may respond to medications targeted to these symptoms even if efficacy is less in the starving brain (Russell et al., 2019). It might be said, however, that food is the miracle drug in anorexia nervosa – if only patients could be persuaded to take it! A number of potentially reversible neurobiological phenomena have been demonstrated including loss of white and grey matter, changes in brain metabolites, altered connectivity (Phillipou et al., 2019) and reward processes secondary to dysregulated endocannabinoids and oxytocin where potential treatment benefits have been demonstrated (Brockmeyer et al., 2018; Russell et al., 2019). Neuromodulation has shown therapeutic promise (Brockmeyer et al., 2018) while at the other end of the body, Commentaries 887792 ANP ANZJP CorrespondenceANZJP Correspondence","PeriodicalId":8576,"journal":{"name":"Australian & New Zealand Journal of Psychiatry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian & New Zealand Journal of Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0004867419887792","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Anorexia nervosa remains vexing to treat with the illness having a decadeslong trajectory in most patients, even those in whom intervention has been early. Despite the severe, enduring and often relapsing course, 75% or more ultimately do recover. Mortality rate from the illness, high though it is, has been reduced with better medical salvage and management of the longterm complications but suicide rate increases after 15 years of illness particularly in the context of substance abuse and socioeconomic disadvantage. Neuroprogression has been mooted but thus far has not been satisfactorily distinguished from the effects of continuing brain starvation (Russell et al., 2019). Anorexia nervosa bears some resemblance to other serious mental illnesses where a substantial number of sufferers remain symptomatic with cognitive and social decline despite what Phillipou et al. (2019) describe rather naively as ‘effective evidencebased treatments’. Genetic studies have shown an overlap between schizophrenia, mood disorders and anorexia nervosa. Autistic social deficits and cognitive rigidity may be premorbid in anorexia nervosa but are exacerbated by weight loss and serve to lock the sufferer into a self-perpetuating vicious cycle. The prospect of eventual full recovery, however, sets anorexia nervosa apart from other serious mental illnesses (Russell et al., 2019). Of course, effective biological treatment for anorexia nervosa does exist – namely refeeding or nutritional rehabilitation. This can bring about complete resolution of physical, endocrine and psychological symptoms, as documented from the earliest descriptions of the condition. However, it is not always easy to effect (or to complete), often unacceptable to patients and even their families who may see it as persecutory. Maintaining the improved state of nourishment is another challenge, with the patient often unable or unwilling to continue with the behavioural changes. Shifting the patient’s mind-set around this and correcting the system of perverse reward in a lasting way continue to be extraordinarily difficult despite involvement of family and friends as cotherapists and numerous proven psychological treatments. These have been informed by the role of diverse factors such as temperament, traits, emotional skills, trauma and distorted body image in aetiogenesis and perpetuation (Keiser et al., 2016; Russell et al., 2019). The main source of difficulty psychologically is that patients with anorexia nervosa with few exceptions differ from patients with most other mental or physical illnesses in that they are unwilling to relinquish their symptoms (i.e. emaciation and engagement in nourishment controlling behaviours) as these seem to assuage a pervasively low sense of self-worth and lack of agency. This reluctance underpins the egosyntonicity, dishonesty and treatment sabotage so frustrating to carers and clinicians (Russell et al., 2019). Patients for their part often feel hopeless to change. Psychotropic medications have been shown to reduce quasi psychotic and obsessive symptoms and to promote weight gain. Anxiety and depression are consequences of prolonged brain starvation (if not premorbid) and may respond to medications targeted to these symptoms even if efficacy is less in the starving brain (Russell et al., 2019). It might be said, however, that food is the miracle drug in anorexia nervosa – if only patients could be persuaded to take it! A number of potentially reversible neurobiological phenomena have been demonstrated including loss of white and grey matter, changes in brain metabolites, altered connectivity (Phillipou et al., 2019) and reward processes secondary to dysregulated endocannabinoids and oxytocin where potential treatment benefits have been demonstrated (Brockmeyer et al., 2018; Russell et al., 2019). Neuromodulation has shown therapeutic promise (Brockmeyer et al., 2018) while at the other end of the body, Commentaries 887792 ANP ANZJP CorrespondenceANZJP Correspondence
神经性厌食症研究进展的生物-心理-社会建议
神经性厌食症的治疗仍然令人烦恼,因为这种疾病在大多数患者身上都有几十年的发展轨迹,即使是那些早期干预的患者。尽管病程严重、持久且经常复发,但75%或更多的患者最终会康复。这种疾病的死亡率虽然很高,但随着更好的医疗救助和对长期并发症的管理,死亡率已经降低,但自杀率在患病15年后上升,特别是在滥用药物和社会经济劣势的情况下。神经进展已被提出,但到目前为止还没有令人满意地将其与持续脑饥饿的影响区分开来(Russell et al., 2019)。神经性厌食症与其他严重的精神疾病有一些相似之处,尽管Phillipou等人(2019)相当天真地将其描述为“有效的循证治疗”,但仍有大量患者出现认知和社交能力下降的症状。基因研究表明,精神分裂症、情绪障碍和神经性厌食症之间存在重叠。自闭症患者的社交缺陷和认知僵化可能在神经性厌食症发病前就有,但体重减轻会加重,并使患者陷入自我延续的恶性循环。然而,最终完全康复的前景将神经性厌食症与其他严重的精神疾病区分开来(Russell et al., 2019)。当然,神经性厌食症的有效生物治疗是存在的——即重新进食或营养康复。这可以带来身体、内分泌和心理症状的完全解决,从最早的病情描述记录。然而,它并不总是那么容易实现(或完成),患者甚至他们的家人往往无法接受,他们可能认为这是一种迫害。维持改善的营养状态是另一个挑战,患者往往不能或不愿继续改变行为。尽管有家人和朋友作为共同治疗师的参与,以及许多经过验证的心理治疗方法,但要改变患者的思维模式,并以一种持久的方式纠正错误的奖励系统,仍然是非常困难的。这些都是由不同因素的作用所决定的,如气质、特质、情感技能、创伤和扭曲的身体形象在病因发生和延续中的作用(Keiser等人,2016;Russell et al., 2019)。心理上困难的主要来源是神经性厌食症患者与大多数其他精神或身体疾病患者的不同之处在于,他们不愿意放弃自己的症状(即消瘦和参与营养控制行为),因为这些症状似乎缓解了普遍存在的低自我价值感和缺乏能动性。这种不情愿助长了自我同心化、不诚实和治疗破坏,这让护理人员和临床医生感到沮丧(Russell等人,2019)。对病人来说,他们常常觉得改变是无望的。精神药物已被证明可以减轻准精神病和强迫症状,并促进体重增加。焦虑和抑郁是长期脑饥饿(如果不是发病前)的后果,即使在饥饿的大脑中疗效较低,也可能对针对这些症状的药物有反应(Russell等人,2019)。然而,可以说,食物是治疗神经性厌食症的灵丹妙药——只要能说服病人吃就好了!已经证明了许多潜在可逆的神经生物学现象,包括白质和灰质的丧失,脑代谢物的变化,连通性的改变(Phillipou等人,2019)以及内源性大麻素和催产素失调的继发奖励过程,其中已经证明了潜在的治疗益处(Brockmeyer等人,2018;Russell et al., 2019)。神经调节已显示出治疗前景(Brockmeyer等人,2018),而在身体的另一端,评论887792 ANP ANZJP通信
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信